Tag: James Breitmeyer

Oncternal begins phase 1b trial of breast cancer drug cirmtuzumab and paclitaxel combo

pharmanewsdaily- September 13, 2018

US oncology company Oncternal Therapeutics said that the first patient enrolled in a phase 1b trial of its investigational breast cancer drug cirmtuzumab in combination ... Read More